NASDAQ:RCEL AVITA Medical (RCEL) Stock Price, News & Analysis $10.87 +0.04 (+0.37%) (As of 09/20/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get AVITA Medical alerts: Email Address About AVITA Medical Stock (NASDAQ:RCEL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get AVITA Medical alerts:Sign Up Key Stats Today's Range$10.69▼$11.0250-Day Range$7.89▼$10.8352-Week Range$7.51▼$18.93Volume298,018 shsAverage Volume203,316 shsMarket Capitalization$280.45 millionP/E RatioN/ADividend YieldN/APrice Target$15.00Consensus RatingHold Company OverviewAVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.Read More… Forget Trump and Kamala (Ad)Forget Trump and Kamala. I don't care who you vote for - This calendar is the only thing that matters right now.Download my Dividend Calendar here AVITA Medical Stock Analysis - MarketRank™See Top Rated MarketRank™ StocksOverall MarketRank™: 28th PercentileAVITA Medical scored higher than 28% of companies evaluated by MarketBeat, and ranked 840th out of 1,006 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingAVITA Medical has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageAVITA Medical has only been the subject of 1 research reports in the past 90 days.Read more about AVITA Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for AVITA Medical are expected to grow in the coming year, from ($2.16) to ($1.25) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of AVITA Medical is -6.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of AVITA Medical is -6.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAVITA Medical has a P/B Ratio of 5.66. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about AVITA Medical's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted5.93% of the float of AVITA Medical has been sold short.Short Interest Ratio / Days to CoverAVITA Medical has a short interest ratio ("days to cover") of 8.4.Change versus previous monthShort interest in AVITA Medical has recently decreased by 9.88%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAVITA Medical does not currently pay a dividend.Dividend GrowthAVITA Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted5.93% of the float of AVITA Medical has been sold short.Short Interest Ratio / Days to CoverAVITA Medical has a short interest ratio ("days to cover") of 8.4.Change versus previous monthShort interest in AVITA Medical has recently decreased by 9.88%, indicating that investor sentiment is improving significantly. News and Social Media0.0 / 5News SentimentN/A Search InterestOnly 1 people have searched for RCEL on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, AVITA Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.82% of the stock of AVITA Medical is held by insiders.Percentage Held by InstitutionsOnly 27.66% of the stock of AVITA Medical is held by institutions.Read more about AVITA Medical's insider trading history. Receive RCEL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AVITA Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address RCEL Stock News HeadlinesAVITA Medical to Present at 2024 Cantor Global Healthcare ConferenceSeptember 12, 2024 | globenewswire.comAVITA Medical to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) ConferenceSeptember 11, 2024 | markets.businessinsider.com Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!September 20, 2024 | Paradigm Press (Ad)AVITA Medical to Participate in Lake Street's 8th Annual Best Ideas Growth (BIG8) ConferenceSeptember 10, 2024 | globenewswire.comAVITA Medical Inc (NASDAQ:RCEL) A Bull Case TheoryAugust 30, 2024 | msn.comTD Cowen Sticks to Its Buy Rating for Avita Medical (RCEL)August 23, 2024 | markets.businessinsider.comAVITA Medical Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsAugust 10, 2024 | finance.yahoo.comRCEL Stock Earnings: AVITA Medical Misses EPS, Beats Revenue for Q2 2024August 8, 2024 | investorplace.comSee More Headlines RCEL Stock Analysis - Frequently Asked Questions How have RCEL shares performed this year? AVITA Medical's stock was trading at $13.72 at the start of the year. Since then, RCEL stock has decreased by 20.8% and is now trading at $10.87. View the best growth stocks for 2024 here. How were AVITA Medical's earnings last quarter? AVITA Medical, Inc. (NASDAQ:RCEL) posted its quarterly earnings results on Thursday, August, 8th. The company reported ($0.60) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.59) by $0.01. The business earned $15.20 million during the quarter, compared to analysts' expectations of $15.04 million. AVITA Medical had a negative net margin of 92.04% and a negative trailing twelve-month return on equity of 118.27%. Who are AVITA Medical's major shareholders? Top institutional investors of AVITA Medical include Bank of New York Mellon Corp (0.28%), Rhumbline Advisers (0.14%), AQR Capital Management LLC (0.09%) and Dimensional Fund Advisors LP (0.09%). Insiders that own company stock include Michael S Perry, Donna Shiroma, Jeremy Curnock Cook, James Corbett and Suzanne Crowe. View institutional ownership trends. How do I buy shares of AVITA Medical? Shares of RCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of AVITA Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that AVITA Medical investors own include NVIDIA (NVDA), Block (SQ), Alibaba Group (BABA), Micron Technology (MU), Netflix (NFLX), PayPal (PYPL) and Twilio (TWLO). Company Calendar Last Earnings8/08/2024Today9/20/2024Next Earnings (Estimated)11/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:RCEL CUSIPN/A CIK1762303 Webwww.avitamedical.com Phone(833) 462-8482FaxN/AEmployees130Year Founded2008Price Target and Rating Average Stock Price Target$15.00 High Stock Price Target$21.00 Low Stock Price Target$9.00 Potential Upside/Downside+39.0%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($1.76) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-35,380,000.00 Net Margins-92.04% Pretax Margin-91.88% Return on Equity-118.27% Return on Assets-52.75% Debt Debt-to-Equity Ratio1.71 Current Ratio5.29 Quick Ratio4.81 Sales & Book Value Annual Sales$54.14 million Price / Sales5.14 Cash FlowN/A Price / Cash FlowN/A Book Value$1.92 per share Price / Book5.62Miscellaneous Outstanding Shares25,800,000Free Float25,330,000Market Cap$278.38 million OptionableOptionable Beta1.54 Social Links 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report This page (NASDAQ:RCEL) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...DealMaker | SponsoredThe Perfect Storm for an EV RevoltWith constant talk about Artifical Intelligence, inflation, and the upcoming election clogging the airwaves......Eagle Publishing | SponsoredTrump’s “Tax Free” Retirement StrategySince 1924 — over one hundred years — the US dollar has lost nearly 18x its value. If you're planning on re...Gold Safe Exchange | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt i...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVITA Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AVITA Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.